Top Keywords: 2019, sitc, asco, final analysis of, final analysis, gm csf, s plus, csf, gm, analysis of, final, plus, trials, influencers, conferences, s, analysis, trastuzumab, reserved, terms of service, of service, in high risk, all rights reserved, figures for, 2019 final, prospective randomized, a prospective, high risk, rights reserved, all rights, breast cancer, multicenter, her2, iib, recurrences, a, Theres a total of 60 keywords.

Statistics

We first found this page on 2023-03-19 00:00:14 +0000. It was last re-indexed on 2024-09-24 14:36:48 +0000 and with a fetch interval of 90 days it will be fetched again in 39 days on 2024-12-23 or soon thereafter.

Last fetch returned code 200, OK, the current page state is ACTIVE.

Traffic Data for clin.larvol.com

If you are the owner of /clin.larvol.com and you want to remove this page from the search results, just use robots.txt

Similar Sites

letetresgene autoleucel (GSK3377794) / Adaptimmune

News for letetresgene autoleucel (GSK3377794) / Adaptimmune
https://delta.larvol.com/Products/?ProductId=820f7bec-269a-4386-84a9-9a882752b452 - Details - Similar

demcizumab (OMP-21M18) / Mereo Biopharma, BMS

News for demcizumab (OMP-21M18) / Mereo Biopharma, BMS
https://delta.larvol.com/Products/?ProductId=b49bfa5d-4278-4a59-920c-895f72de9a49&Index=0 - Details - Similar

TAC101-Claudin18.2 / Triumvira

News for TAC101-Claudin18.2 / Triumvira
https://delta.larvol.com/Products/?ProductId=6c67a8c2-e9ec-40b8-82fc-3db2d5bcbe47&Index=0 - Details - Similar

pogalizumab (MOXR0916) / Roche

News for pogalizumab (MOXR0916) / Roche
https://delta.larvol.com/Products/?ProductId=7591eddc-448c-4182-b56c-3a445f36dc22 - Details - Similar

More sites similar to ASCO-SITC 2019: Final analysis of Nelipepimut-S plus GM-CSF with trast...

Find Another Website

Search - Add URL

Sponsored Results

Your Ad Here & Hundreds of Other ISEDN Engines & Directories- $3/Month or Less

Your Ad Here & Hundreds of Other ISEDN Engines & Directories- $3/Month or Less